Maria del Carmen Ramos Martín;Sonia Campoy García;Saleta Sierra Ávila;Javier Santos Burgos Muñoz;Ángel ;Juan María Alfaro Sánchez;Carlos Ramírez Moreno;José Luis Adrio Fondevila;Javier Velasco Alvarez
发明人:
Javier Santos Burgos Muñoz,José Luis Adrio Fondevila,Maria del Carmen Ramos Martín,Saleta Sierra Ávila,Juan María Alfaro Sánchez,Carlos Ramírez Moreno,Sonia Campoy García,Javier Velasco Alvarez,Ángel
申请号：
US13264167
公开号：
US20120095091A1
申请日:
2010.04.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention describes a compound of formula (I)its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for its use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with undesired oxidation, age-associated pathological processes and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, or fungal or viral infections.
